Literature DB >> 15566741

Early kinetics of antibody response to inactivated influenza vaccine.

R Pyhälä1, S Alanko, T Forsten, K Haapa, L Kinnunen, M Jääskivi, R Visakorpi, M Valle.   

Abstract

The aim was to examine the rapidity of haemagglutination inhibiting (HI) antibody response induced by immunization with a current inactivated trivalent influenza vaccine. Five to six sequential serum samples collected in autumn 1992 from each of 68 vaccinees in three age groups were studied for HI antibodies to ten influenza virus strains representing vaccine and epidemic viruses. Geometric mean titres, response rates and protection rates are presented. Response rates of > 70% were overall, but not until two weeks after the vaccination. Significant two- and four-day post-vaccination antibody responses were detected only occasionally. In previously vaccinated persons, average antibody titres to some of the viruses decreased during the first days after the vaccination. In the subsequent samples, the titres remained lower than in persons who were not vaccinated against influenza in preceding years. Protection against influenza infection may be frequently developed not until two weeks after vaccination. This has relevance to prophylactic administration of amantadine and rimantadine when an influenza A outbreak is imminent and the vaccination is late.

Entities:  

Year:  1994        PMID: 15566741     DOI: 10.1016/0928-0197(94)90057-4

Source DB:  PubMed          Journal:  Clin Diagn Virol        ISSN: 0928-0197


  4 in total

1.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

2.  Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial.

Authors:  Kyuri Kang; Seunghoon Han; Taegon Hong; Sangil Jeon; Jeongki Paek; Jin Han Kang; Dong Seok Yim
Journal:  Yonsei Med J       Date:  2016-11       Impact factor: 2.759

3.  Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis.

Authors:  S P H van den Berg; K Warmink; J A M Borghans; M J Knol; D van Baarle
Journal:  Med Microbiol Immunol       Date:  2019-04-04       Impact factor: 3.402

4.  Perception of COVID-19 Booster Dose Vaccine among Healthcare Workers in India and Saudi Arabia.

Authors:  Sajith Vellappally; Sachin Naik; Omar Alsadon; Abdulaziz Abdullah Al-Kheraif; Haya Alayadi; Areej Jaber Alsiwat; Aswini Kumar; Mohamed Hashem; Nibu Varghese; Nebu George Thomas; Sukumaran Anil
Journal:  Int J Environ Res Public Health       Date:  2022-07-22       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.